These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1020 related items for PubMed ID: 32173225

  • 21. Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm.
    Chen X, Delcourt C, Sun L, Zhou Z, Yoshimura S, You S, Malavera A, Torii-Yoshimura T, Carcel C, Arima H, Hackett ML, Robinson T, Song L, Wang X, Lindley RI, Chalmers J, Anderson CS, ENCHANTED Investigators.
    Cerebrovasc Dis; 2020; 49(4):427-436. PubMed ID: 32702699
    [Abstract] [Full Text] [Related]

  • 22. The Risk of Hemorrhagic Transformation After Thrombolysis for Acute Ischemic Stroke in Chinese Versus North Americans: A Comparative Study.
    Xu X, Wang D, Wang F, Norton C, Liu X, Selim M.
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2381-2387. PubMed ID: 29778315
    [Abstract] [Full Text] [Related]

  • 23. Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study.
    Wang X, Song L, Yang J, Sun L, Moullaali TJ, Sandset EC, Delcourt C, Lindley RI, Robinson TG, Minhas JS, Arima H, Chalmers J, Kim JS, Sharma V, Wang JG, Pontes-Neto O, Lavados PM, Olavarría VV, Lee TH, Levi C, Martins SO, Thang NH, Anderson CS, on behalf of the ENCHANTED Investigators.
    Cerebrovasc Dis; 2019 Sep; 48(3-6):207-216. PubMed ID: 31812956
    [Abstract] [Full Text] [Related]

  • 24. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
    Aoki S, Hosomi N, Sueda Y, Kono T, Takamatsu K, Ohyama H, Torii T, Kitamura T, Nomura E, Noda K, Ohtsuki T, Matsumoto M, HARP Registry Study Group.
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972
    [Abstract] [Full Text] [Related]

  • 25. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
    Hsu PJ, Chen CH, Yeh SJ, Tsai LK, Tang SC, Jeng JS.
    Cerebrovasc Dis; 2016 Dec; 42(1-2):117-21. PubMed ID: 27088493
    [Abstract] [Full Text] [Related]

  • 26. Late Hospital Arrival for Thrombolysis after Stroke in Southern Portugal: Who Is at Risk?
    Sobral S, Taveira I, Seixas R, Vicente AC, Duarte J, Goes AT, Durán D, Lopes J, Rita H, Nzwalo H.
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):900-905. PubMed ID: 30606619
    [Abstract] [Full Text] [Related]

  • 27. Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial.
    Minhas JS, Wang X, Arima H, Bath PM, Billot L, Broderick JP, Donnan GA, Kim JS, Lavados PM, Lee TH, Martins SCO, Olavarría VV, Pandian JD, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Thang NH, Wang JG, Woodward M, Chalmers J, Anderson CS, Robinson TG, ENCHANTED Investigators.
    Cerebrovasc Dis; 2018 Apr; 45(5-6):213-220. PubMed ID: 29705803
    [Abstract] [Full Text] [Related]

  • 28. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW, Zhang XJ, Cheng LS, Li GY, Zhang LJ, Ji KX, Zhao Q, Bai Y.
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [Abstract] [Full Text] [Related]

  • 29. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG, Chaudhry SA, Hassan AE, Peacock JM, Lakshminarayan K, Tsai A, Luepker R, Anderson DC, Qureshi AI.
    Cerebrovasc Dis; 2012 Feb; 34(5-6):400-5. PubMed ID: 23221276
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke.
    Nagaraja N, Tasneem N, Shaban A, Dandapat S, Ahmed U, Policeni B, Olalde H, Shim H, Samaniego EA, Pieper C, Ortega-Gutierrez S, Leira EC, Adams HP.
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1403-1411. PubMed ID: 29398533
    [Abstract] [Full Text] [Related]

  • 32. A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic stroke.
    Adeoye O, Knight WA, Khoury J, Schmit PA, Sucharew H, Broderick JP, Pancioli AM, CLEAR-ER Investigators.
    J Stroke Cerebrovasc Dis; 2014 May; 23(5):e313-5. PubMed ID: 24534128
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Thrombolysis for acute ischemic stroke.
    Hajjar K, Kerr DM, Lees KR.
    J Vasc Surg; 2011 Sep; 54(3):901-7. PubMed ID: 21889708
    [Abstract] [Full Text] [Related]

  • 38. Thrombolysis with alteplase 3-4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China.
    Zheng H, Yang Y, Chen H, Li C, Chen Y, Shi FD, Yang L, Cui X, Lu Z, Liang Y, Cui S, Xu A, Wu Y, Sun Y, Wang Y.
    Stroke Vasc Neurol; 2020 Sep; 5(3):285-290. PubMed ID: 32467323
    [Abstract] [Full Text] [Related]

  • 39. A Fall in Systolic Blood Pressure 24 Hours after Thrombolysis for Acute Ischemic Stroke Is Associated with Early Neurological Recovery.
    Gill D, Cox T, Aravind A, Wilding P, Korompoki E, Veltkamp R, Kar A.
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1539-43. PubMed ID: 27053029
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.